Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Watchlisten für Ihre Werte
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON

Business Leaders

Aktuelle NewsUnternehmenMärkteWirtschaft & ForexRohstoffeZinssätzeBusiness LeadersInstitutionelle AnlegerTermineSektoren 
HomeAlle NewsMeistgelesene ArtikelBusiness Leaders Biografien
Portrait de Jeffrey S. Aronin
Alter : 53
Vermögen : 12 360 141 USD
Größte Unternehmen : Discover Financial Services - Harmony Biosciences Holdings, Inc.
Übersicht 
Jeffrey S. Aronin is an entrepreneur and businessperson who founded 7 companies, among them: OVATION Pharmaceuticals, Inc., Paragon Biosciences LLC and Emalex Biosciences, Inc. and who has been at the head of 10 different companies. Presently, Jeffrey S. Aronin occupies the position of Chairman & Chief Executive Officer of Paragon Pharmaceuticals Capital LLC, Co-Chairman of MATTER Chicago (which he founded), Non-Executive Chairman of Harmony Biosciences Holdings, Inc., Chairman & Chief Executive Officer at Paragon Biosciences LLC (which he founded in 2010), Chairman & Chief Executive Officer of Emalex Biosciences, Inc. (which he founded), Chairman for Castle Creek Biosciences, Inc. (which he founded in 2018) and Director & Manager at Paragon Biosciences Skyline Capital LLC. Mr. Aronin is also on the board of 14 other companies.

He previously held the position of Chairman & Chief Executive Officer at Marathon Pharmaceuticals LLC, Special Advisor at Merrick Ventures LLC, Chairman & Chief Executive Officer at Enterprise Technologies, Inc., President & Chief Executive Officer at OVATION Pharmaceuticals, Inc. (he founded the company in 2000), President & Chief Executive Officer of Lundbeck, Inc. (he founded the company in 2000) and Vice President-Marketing & Business Development at American Health Products Corp.

He received an undergraduate degree from Northern Illinois University and an MBA from DePaul University.


Aktuelle Stellungen und Verantwortungsbereiche Jeffrey S. Aronin 
NameTitel Seit
Discover Financial Services
(Banken)
Independent Director 2008
Harmony Biosciences Holdings, Inc.
(Pharmazeutika)
Non-Executive Chairman 2017
Paragon Pharmaceuticals Capital LLC Chairman & Chief Executive Officer 2010
Emalex Biosciences, Inc. Chairman & Chief Executive Officer -
Paragon Biosciences LLC Chairman & Chief Executive Officer 2010
Castle Creek Biosciences, Inc. Chairman 2018
MATTER Chicago Co-Chairman -
CIRC Biosciences, Inc. Director -
The University of Chicago Medical Center Director -
Skyline Biosciences LLC Director -
Qlarity Imaging LLC Director -
Paragon Biosciences Qlarity Capital, Inc. Director -
Castle Creek Pharmaceutical Holdings, Inc. Director -
Paragon Biosciences Skyline Capital LLC Director & Manager -
Paragon Biosciences Emalex Capital, Inc. Director -
Harmony Biosciences LLC Director -
Castle Creek Pharmaceuticals LLC Director 2015
Ravinia Festival Association Trustee -
Pharmaceutical Research & Manufacturers of America Director 2010
The Commercial Club of Chicago Director -
The Aspen Institute, Inc. Director -


Anteile an Jeffrey S. Aronin 
NameAktien%Wert
Harmony Biosciences Holdings, Inc. (HRMY)
(Pharmazeutika)
251 9220,43%10 741 954 USD
Discover Financial Services (DFS)
(Banken)
14 0030,0048%1 618 187 USD


Jeffrey S. Aronin: Persönliches Netzwerk 
Meistgelesene News 
11.01.JAMIE DIMON : JPMorgan's Dimon sagt, dass es 6-9 Monate dauern kann, bis sich das Wachstum der Verbraucherkredite wieder normalisiert
MR
14.01.ELON MUSK : Tesla-Waren können mit Dogecoin gekauft werden, sagt Musk in einem Tweet
MR
14.01.JACK DORSEY : Jack Dorseys Block will ein offenes Bitcoin-Schürfsystem aufbauen
MR
10.01.BRUNELLO CUCINELLI : Luxuskonzern Cucinelli verzeichnet 31% Umsatzplus im Jahr 2021
MR
07.01.CHRISTIAN KLEIN : Deutschlands Vorzeige-Tech-Konzern am Scheideweg
DP
07.01.TIM COOK : Apple-Chef Cook erhält für 2020 fast 100 Millionen Dollar
RE
12.01.MARTIN SORRELL : Sorrells S4 übertrifft die Prognosen bei weitem
MR
10.01.PAUL SCHULER : Jahresumsatz von 9,15 Milliarden Franken erwartet
AW
10.01.Estelle Brachlianoff wird nächste CEO von Veolia
MR
12.01.GORDON RISKE : Mit neuem Chef ins neue Jahr
DP
Weitere Nachrichten und Newsletter


© 2022 People and Ownership :   
Jeffrey S. Aronin : Verbindungen